← Back to Search

Behavioral Intervention

SHAG (Sexual Health Advocacy for Guys) for Human Immunodeficiency Virus Infection (SHAG Trial)

N/A
Recruiting
Research Sponsored by Center for Innovative Public Health Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Assigned male sex at birth and currently have a cisgender identity
Aged 13-20 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention, 3-months post, 6-months post, 9-months post, 12-month post
Awards & highlights

SHAG Trial Summary

This trial is testing a program called SHAG that uses text messaging to help prevent HIV in young boys and men who are attracted to the same sex. The program will be compared to a control group that

Who is the study for?
This trial is for cisgender sexual minority boys and men aged 13-20 in the U.S. who are interested in participating in an HIV prevention program. The eligibility criteria details are not fully provided, so additional requirements may apply.Check my eligibility
What is being tested?
The SHAG program, which uses text messaging to prevent HIV among young guys into guys, is being tested against a control group that receives texts about maintaining a healthy lifestyle.See study design
What are the potential side effects?
Since this trial involves educational text messages rather than medical treatments, there aren't typical side effects like with drugs or surgeries. However, participants might experience increased stress or anxiety related to sexual health discussions.

SHAG Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was born male and identify as a man.
Select...
I am between 13 and 20 years old.

SHAG Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, 3-months post, 6-months post, 9-months post, 12-month post
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention, 3-months post, 6-months post, 9-months post, 12-month post for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HIV Incidence
Secondary outcome measures
Proportion of Participants Testing for an STI
Proportion of Participants having used PrEP/PEP
Self-reported HIV incidence

SHAG Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SHAG (Sexual Health Advocacy for Guys)Experimental Treatment1 Intervention
Young people assigned to the intervention arm will receive ~9 weeks of daily text messages that talk about healthy sexuality and ways to reduce HIV risk. After a 3 month 'quiet' period, they will receive a week of review messages. Messages are based upon the information-motivation-behavioral model of preventive behavior.
Group II: Attention-matched controlPlacebo Group1 Intervention
Young people assigned to the control arm will receive ~9 weeks of daily text messages that talk about healthy lifestyle, such as self-esteem and physical exercise. After a 3 month 'quiet' period, they will receive a week of review messages.

Find a Location

Who is running the clinical trial?

Center for Innovative Public Health ResearchLead Sponsor
9 Previous Clinical Trials
2,898 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals who are 18 years old or older eligible to participate in this medical study?

"Prospective participants who are between the ages of 13 and 20 may be eligible for this trial. Notably, there are a total of 109 studies available specifically for individuals under the age of 18, while there are 330 studies catering to patients over the age of 65."

Answered by AI

How large is the participant pool for this particular medical study?

"Indeed, the data available on clinicaltrials.gov confirms that this trial is actively seeking participants. The initial posting date for the study was January 15th, 2024, and it underwent its most recent update on January 19th, 2024. To complete the trial successfully, a total of 5000 patients are needed from a single site or location."

Answered by AI

Is the enrollment of participants still ongoing for this clinical trial?

"As per the current information available on clinicaltrials.gov, this trial is actively seeking eligible candidates. The trial was initially posted on January 15th, 2024 and has been recently updated on January 19th, 2024."

Answered by AI
~3333 spots leftby Jul 2026